Bicoll presents at IZB brunch
Dr. Kai Lamottke presents the last results of the drug discovery development during the monthly IZB brunch on the 20th of July at the leading European biotech cluster. Read the program here.
Bicoll lecture for Max-Plank InPharma Innovation Initiative
Bicoll Managing Director, Dr. Kai Lamottke, hosts at Bicoll headquaters Max-Plank InPharma Innovation Initiative 3Is.
Steering Committee meeting of EpimiRNA
Bicoll Managing Director, Dr. Kai Lamottke, joins Steering Committee of EpimiRNA in Amsterdam to discuss the achievements in epilepsy research. Read more in EpimiRNA publications.
29 Natural Compounds days
Bicoll takes part in the 29th Natural Compounds days Naturstofftage, Bavaria, Germany.
MicroRNAs in epilepsy: pathophysiology and clinical utility
Prof. David C. Henshall, Prof. Hajo M. Hamer, MD, Prof. R. Jeroen Pasterkamp, PhD, Prof. David B. Goldstein, PhD, Prof. Jørgen Kjems, PhD, Prof. Jochen H. M. Prehn, PhD, Stephanie Schorge, PhD, Kai Lamottke, PhD, Felix Rosenow, MD, THE LANCET …
Fourth General Assembly of EpimiRNA
Bicoll as a work package leader is visiting Copenhagen, Denmark as a part of Epilepsy Consortium EpimiRNA. Read more about the last results on the topic of epilepsy treatment.
Bicoll expands the activities in Seoul
As a part of the Bavarian delegation of Bio-M and Bayern International Bicoll is visiting Seoul, Chuncheon und Cheongju / Daejeon.
Bicoll is going Asia
Internationalization strategy of European’s leading Biotech Cluster in Munich grant-aided: Dr. Kai Lamottke, Bicoll, as an industry cluster representative together with Dr. Wehnelt from Bio-M, the networking agency for the biotechnology sector in Munich and Bavaria, have successfully defended the …
Going Asia: German ministry supports Biotechnology
Internationalization strategy of European’s leading Biotech Cluster in Munich grant-aided: Dr. Kai Lamottke, Bicoll, as an industry cluster representative together with Dr. Wehnelt from Bio-M, the networking agency for the biotechnology sector in Munich and Bavaria, have successfully defended the …